Further insights into our reserving policy

Similar documents
Group risk management update

Capital position and risk profile

From the CFO's desk. How to read the run-off result / Update on yield expectations. Roland Vogel, Chief Executive Officer

1 Jan 2016 Property & Casualty Treaty Renewals

19th International Investors' Day

Health & Special Risk. The New York office of Hannover Re specializes in health and special risk products and services

Conference Call on Half-yearly Report 2016

Vontobel Summer Conference

Conference Call on Interim Report 3/2017

Press Conference. Annual Results Hannover, 7 March 2019

Implementing the strategy Alex Wynaendts CEO Analyst & Investor Conference, London June 22-23, 2010

Hannover Re - growth opportunities despite the crisis? Ulrich Wallin Chief Executive Officer

Conference Call on Q1/2018 results

1 Jan 2018 Property & Casualty Treaty Renewals. and guidance update 2017 and 2018

Hannover Rück SE / E+S Rück AG

The relevance of cash flow in P&C reinsurance. Jürgen Gräber, Member of the Executive Board

European Embedded Value (EEV) Introduction. 2 Covered Business. 3 European Embedded Value 2006 and its Components

Link between Pillar 1 and Pillar 2

Solvency II Update. Latest developments and industry challenges (Session 10) Réjean Besner

IT ONLY TAKES ONE INDEX TO CAPTURE THE WORLD THE MODERN INDEX STRATEGY. msci.com

Hannover Re's Analysts' Conference

Welcome to Hannover Re's Analysts' Conference

From the CFO's desk. Roland Vogel, Chief Financial Officer

Insurance data sources and data needs: Private-sector perspectives. Raymond Yeung, Swiss Re OECD-Asia Regional Seminar, September 23-24, Kuala Lumpur

Recent Solvency II Developments for European Life Insurers and Hannover Life Re. Dr. Wolf S. Becke CEO Hannover Life Re

Hannover Re - The somewhat different reinsurer

Business Performance & Strategy. Separate Financial Result as of FY

Growth and profit opportunities in P&C R/I. Jürgen Gräber, Member of the Executive Board

ORSA An International Development

21st International Investors' Day

EVEREST RE GROUP, LTD LOSS DEVELOPMENT TRIANGLES

Investor Presentation

US Mortality Solutions

Connecting Our Clients to Global Investment Opportunities

FTSE All-World ex Fossil Fuels Index Series

Growth and profit drivers in non-life R/I

MANDATORY PROVIDENT FUND SCHEMES AUTHORITY

METHODOLOGY BOOK FOR:

MANDATORY PROVIDENT FUND SCHEMES AUTHORITY. Guidelines on Recognized Exchanges

The Changing face of ERM: The Insurance Company s Perspective

HOW DO YOU DEFINE YOUR BORDERS? THE MODERN INDEX STRATEGY. msci.com

Welcome to Hannover Re's Analysts' Conference. Annual Results 2017

HOW DO YOU DEFINE YOUR BORDERS? THE MODERN INDEX STRATEGY. msci.com

FTSE Global RIC Capped Indexes

Real Estate Investment Beyond(?) the Global Credit Crisis

Results for the six months ended 30 June 2017

NEUBERGER BERMAN Environmental, Social and Governance Policy

MANDATORY PROVIDENT FUND SCHEMES AUTHORITY

Half Year Report 2016

Developments & Insights in Singapore RBC 2 and Overview of ORSA across Regions

May Global Growth Strategy

Creditor and Lifestyle Protection Insurance

Financial Stability (EX) Task Force

First ever quarter with over 200m Gross Profit

BASEL III Basel Committee on Banking Supervision (BCBS)

FTSE Global Equity Index Series

Global Tax Reset Transfer Pricing Documentation Summary. February 2018

Merrill Lynch Banking & Insurance Conference

The bank safety net: institutions and rules for preserving the stability of the banking system

MSCI MARKET NEUTRAL BARRA FACTOR INDEXES METHODOLOGY

Creating value through reinsurance

DJSI Diversified Family

NORTH AMERICAN UPDATE

Solvency II. Insurance and Pensions Unit, European Commission

29th India Fellowship Seminar

Sasol International Insurance DAC

EIOPA Proposal for Guidelines on the preparation for Solvency II. October Milliman Solvency II Update

CLAIMANT S STATEMENT AND AUTHORIZATION

Global Insurance and Lending Market Data: Size, Segmentation and Forecast for Worldwide Markets

Franklin Templeton Investments Our Global Perspective

Reinsurance s qualitative contribution to value added within the framework of Pillar 2 of

Quarterly Investment Update First Quarter 2017

Global Select International Select International Select Hedged Emerging Market Select

July 2012 Chartbook The Halftime Report

June Vanguard Equity Index Fund Benchmark Changes Overview of the Transition Process

Thomas Buberl Group CEO, AXA. Bank of America Merrill Lynch Conference London September 27, 2018

FTSE Global All Cap Index

Bank of America Merrill Lynch Global Securities Operations

Actuaries Club of the Southwest

This article is on Capital Adequacy Ratio and Basel Accord. It contains concepts like -

SOLVENCY II INSIGHTS FOR NORTH AMERICAN INSURERS. CAS Centennial Meeting Melissa Salton November 10, 2014

Cashflow Management. Annemarie Moore Group Treasurer Plan International

Investor Presentation. 53,000 employees, 200 offices, 75 countries, 1 global platform

2013 Conference Risk, Recovery & Real Growth" 23rd Annual CAA Conference Secrets Wild Orchid Montego Bay, Jamaica. 4 th to 6 th December 2013

METHODOLOGY BOOK FOR:

Another quarter of double digit growth

Risk Appetite for Life Offices IFoA working party


A Global Economic and Market Outlook

Managing the capital of a re/insurance group today

Allianz Re. Company Presentation. May Understanding Risk Creating Value

Current status of Solvency II and challenges down the line. Matthew Edwards 11 October 2011

Sal. Oppenheim European Financial Conference

GLOBAL EMERGING MARKETS: IT IS THE STOCKS THAT MATTER ANWAAR WAGNER

INSURANCE: RISK TRANSFER SOLUTIONS IN THE INSOLVENCY SPACE

Solvency II goes global

Report for the six months to June 30, 2012

LIBERTYQ GLOBAL DIVIDEND INDEX

INTERNATIONAL ASSOCIATION OF INSURANCE SUPERVISORS

DOES YOUR PORTFOLIO REFLECT EUROPE? THE MODERN INDEX STRATEGY. msci.com

Transcription:

Further insights into our reserving policy and Solvency II Eberhard Müller, CRO/Group Risk Management 15th International Investors' Day London, 18 October 2012

Overview 1. Reserving policy Our Reserving Framework Update on reserve figures 2. Enterprise risk management Our Risk Management approach Enterprise risk management 3. Solvency II Further insights into our reserving policy

Two segments of reserves in our balance sheet Recent figures from year-end 2011 Total gross reserves* Hannover Re Group EUR 31,078 m. Non-life E+S Rück 2,512 Non-life branches 1,506 8% 5% Non-life R/I EUR 18,030 m. Non-life subsidiaries 2,830 9% Life and health R/I EUR 10,309 m. benefit reserve EUR 2,739 m. loss reserve 42% Life and health 13,048 Non-life Hannover Re 11,182 36% * As at 31 December 2011, consolidated, IFRS figures Stable shares: non-life 58%, life and health 42% 1 Further insights into our reserving policy

Our reserving policy Confirmed in our new high-level framework reserving guideline Goal: Consistent reserving standards and processes Field of application: non-life and life & health reinsurance segments within Hannover Re Group Clearly defined tasks, authorities and responsibilities for all departments and staff involved in the reserving process Reserving process Definition of risk tolerance Risk control process: identification, analysis, evaluation, steering, monitoring and reporting of reserving risks 2 Further insights into our reserving policy

Diversified gross life & health reserves Total gross L&H reserves HR Group EUR 13,048 m. Europe 1,175 Rest of World 1,440 9% 11% Germany (Hannover Re/E+S Rück) UK/Ireland (HLR UK, HLR Ir) US (HLR US) US 1,946 15% 43% Germany 5,646 Europe (Branches in Stockholm and France) Rest of World 22% * As at 31 December 2011, consolidated, IFRS figures UK/Ireland 2,841 Subsidiaries (Australia, Bermuda, Africa, Takaful in Bahrain) Branches (Shanghai, Korea, Hong Kong, Malaysia)...with reduced volatility compared to non-life reserves 3 Further insights into our reserving policy

Reserve monitoring in life & health Further processes and monitoring steps by GRM RES MCEV contract with Deloitte since two years coordinated by GRM RES and signed by CEO and CRO External reserve review with Towers Watson as peer review of Deloitte reserve reports Internal reserve reports by GRM RES (for example accident & health) Treaty monitoring function of larger treaties Check of pricing, data, sensitivities, cash-flows Agreed reporting thresholds with Home Office and local entities Support for pandemic scenario analysis (plausibility checks) Support for capital impact assessment of huge treaties (defined by premium volume, reserves/deposits or sum at risk) 4

Our well-diversified non-life business......is also reflected in our loss reserves across entities and countries Total gross non-life reserves HR Group EUR 18,030 m. Group-wide non-life reserve study (internal and external) Rest of World 3,652 Hannover Re/E+S Rück, Canada, Bahrain, Takaful 20% 26% USA 4,725 calculations by GRM RES: EUR 14,115 m. (78%) Bermuda, Australia, Malaysia, Shanghai UK/Ireland 3,719 21% 15% by external appointed actuaries: EUR 1,660 m. (9%) 18% Germany 2,703 UK(IICH), Ireland, Sweden, South Africa Europe 3,231 by HR Group own actuaries: EUR 2,255 m. (13%) * As at 31 December 2011, consolidated, IFRS figures 5 Further insights into our reserving policy

About 45% related to general liability Driven by premium volume in recent U/Y Gross non-life reinsurance loss reserves* EUR 13,694 m. Motor liability 2,599 19% 44% General liability 6,045 37% Other 5,050 * HR and E+S as at 31 December 2011, consolidated, IFRS figures 6 Further insights into our reserving policy

Estimation system & bulk IBNR Roughly one half of own IBNR is self-made Home-made IBNR* EUR 13,694 m. Cedent-advised reserves 6,419 47% 53% Additional IBNR 7,275 * HR and E+S as at 31 December 2011, consolidated, IFRS figures 7 Further insights into our reserving policy

Reported loss triangles*... Reconciliation to our balance sheet in m. EUR No. Line of business Hannover Re/ E+S Rück Total reserves U/Y 1979-1999 U/Y 1979-1999 in % of HR Group Total reserves U/Y 2000-2011 U/Y 2000-2011 in % of HR Group 1 General liability non-prop. 391.5 2.2% 36,750.0 20.4% 2 Motor non-prop. 438.0 2.4% 1,558.2 8.6% 3 General liability prop. 154.0 0.9% 1,567.9 8.7% 4 Motor prop. 139.4 0.8% 759.6 4.2% 5 Property prop. 18.7 0.1% 1,048.9 5.8% 6 Property non-prop. 7.1 0.0% 739.4 4.1% 7 Marine 25.5 0.1% 847.7 4.7% 8 Aviation 39.0 0.2% 851.3 4.7% 9 Credit/surety 27.5 0.2% 831.7 4.6% Total All lines of business 1,240.8 6.9% 11,879.7 65.9% * As at 31 December 2011, consolidated, IFRS figures...represent about 3/4 of our gross carried reserves 8 Further insights into our reserving policy

Data description and information Understanding the data is crucial for interpretation, analysis and results Statistical gross reported loss triangles based on cedents' original advices (paid and case reserve information) Converted to EUR with exchange rates as at 31 December 2011 Figures in triangles do not include business written in branch offices and subsidiaries Data on underwriting-year basis Data are combined triangles for companies HR and E+S Rück 9 Further insights into our reserving policy

Reported claims triangle for HR/E+S* Total (~2/3 of HR Group reserves shown in 9 individual triangles) Statistical data (as provided by cedants) Booked data U/W IFRS earned Ultimate Paid Case IBNR year premium 12 24 36 48 60 72 84 96 108 120 132 144 loss ratio losses reserves balance 2000 2,486 64.7% 93.0% 104.9% 108.2% 110.1% 112.8% 111.5% 112.1% 112.3% 112.2% 111.8% 111.8% 115.6% 100.8% 11.1% 3.7% 2001 3,299 69.0% 80.4% 86.5% 91.7% 92.1% 93.6% 94.2% 95.4% 96.1% 95.7% 96.1% 99.8% 87.7% 8.0% 4.0% 2002 3,796 43.7% 50.3% 52.9% 55.2% 55.8% 56.3% 56.4% 56.6% 56.6% 56.6% 61.0% 52.0% 4.4% 4.5% 2003 3,732 30.0% 39.2% 41.9% 43.9% 44.9% 45.5% 46.1% 46.7% 46.7% 53.5% 40.6% 5.7% 7.1% 2004 3,419 31.1% 45.0% 48.6% 50.6% 52.5% 53.3% 54.0% 54.1% 63.8% 47.6% 6.5% 9.7% 2005 3,699 54.3% 71.9% 77.1% 79.8% 81.7% 82.9% 83.5% 95.8% 75.7% 8.1% 12.0% 2006 3,538 30.4% 39.0% 41.9% 44.4% 45.8% 47.1% 62.1% 38.2% 8.6% 15.3% 2007 3,488 35.9% 49.1% 53.9% 56.9% 58.6% 77.1% 47.1% 11.7% 18.4% 2008 3,515 38.1% 53.9% 59.3% 61.8% 84.1% 45.4% 15.1% 23.6% 2009 3,780 32.3% 45.4% 48.9% 75.8% 31.5% 16.0% 28.4% 2010 3,900 37.1% 50.4% 84.1% 28.4% 20.4% 35.3% 2011 2,605 42.1% 85.6% 12.8% 17.6% 55.3% 120% 100% 80% 60% 40% 20% 0% 12 24 36 48 60 72 84 96 108 120 132 144 140% 120% 100% 80% 60% 40% 20% 0% 00 01 02 03 04 05 06 07 08 09 10 11 4,500 4,000 3,500 3,000 2,500 2,000 1,500 1,000,500 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 * As at 31 December 2011 (in m. EUR), consolidated, IFRS, development in months Paid losses IBNR IFRS gross written premium Case reserves IFRS earned premium 10 Further insights into our reserving policy

Reported claims triangle* Example: Motor/Accident non-proportional (HR/E+S) Statistical data (as provided by cedents) Booked data U/W IFRS earned Ultimate Paid Case IBNR year premium 12 24 36 48 60 72 84 96 108 120 132 144 loss ratio losses reserves balance 2000 94 37.4% 56.2% 67.5% 85.1% 89.9% 95.0% 95.3% 97.3% 97.9% 100.8% 100.9% 103.4% 122.6% 68.9% 34.7% 19.0% 2001 105 25.3% 43.1% 55.4% 61.1% 65.3% 71.6% 72.7% 75.1% 75.2% 75.1% 74.9% 94.8% 48.1% 26.5% 20.2% 2002 155 32.0% 49.0% 59.3% 63.6% 66.2% 67.4% 68.8% 70.5% 71.6% 72.5% 94.9% 45.4% 26.8% 22.7% 2003 198 19.6% 39.5% 45.6% 51.8% 53.2% 54.0% 55.0% 55.2% 55.9% 78.0% 35.3% 20.1% 22.5% 2004 230 21.7% 34.2% 43.8% 48.1% 52.6% 53.2% 53.6% 54.9% 81.4% 32.5% 22.2% 26.7% 2005 265 16.6% 30.4% 36.5% 41.5% 43.1% 43.3% 44.9% 76.3% 26.2% 18.6% 31.5% 2006 248 21.6% 32.3% 38.1% 42.9% 45.1% 47.2% 82.3% 27.3% 19.8% 35.3% 2007 235 28.1% 43.7% 51.6% 56.4% 57.6% 108.2% 34.6% 22.6% 51.0% 2008 221 57.0% 66.6% 72.8% 77.8% 131.4% 58.0% 19.2% 54.1% 2009 230 17.7% 31.5% 40.2% 99.7% 16.0% 23.0% 60.8% 2010 221 14.8% 22.4% 101.4% 4.5% 17.2% 79.8% 2011 184 22.0% 97.1% 3.3% 15.9% 77.8% 120% 100% 80% 60% 40% 20% 0% 12 24 36 48 60 72 84 96 108 120 132 144 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 150% 125% 100% 75% 50% 25% 0% Paid losses IBNR IFRS gross written premium Case reserves IFRS earned premium 300 250 200 150 100 50 0 * As at 31 December 2011 (in m. EUR), consolidated, IFRS, development in months 11 Further insights into our reserving policy

Reported claims triangle Example: motor/accident non-proportional (HR/E+S) Data and information shown on previous slide consists of data from 16 individual reserving segments Business shown includes motor liability (66% of underlying earned premium) motor non-liability accident Average ultimate loss ratio of 96%: still 2/3 of booked ultimate is held in reserves For motor liability business only (U/Y 2000-2011) 75% of total booked ultimate is currently reserved as case reserve (25%) and IBNR (50%) only 25% are paid 96% ULR 44% IBNR 21% Case Res. 31% Paid 12 Further insights into our reserving policy

US/Bermuda liability non-proportional: looks promising On average still ~7%pts higher ULRs than mature years suggest Ultimate Loss Ratios (ULR) in % 86 51 59 58 65% average ULR 54% average paid ratio 67% average ULR 60% average ULR "as-if" 68 54 65 62 54 66 57 74 52 64 43 45 44 50 46 69 48 32 33 31 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 ULR (as 12/2011) + realised + projected part to complete 10th-year paid ratio ULR ("as if": 65% - 54% + + ) 13

Individual aspects Special A&E reserves A&E reserves 2011 due to slightly decreased 3-year average paid on a very high level Survival ratio 25.9 years Bulk IBNR increased due to f/x effects (12/2011: 1 EUR = 1,29457 USD, 12/2010: 1 EUR = 1,32542 USD) IBNR factor 2011 (6.8) still well above Towers Watson-recommendation of 5.0 Financial year Case reserves HR additional reserves for A&E (in TEUR) Total reserve for A&E (in TEUR) 3-year-average paid (in TEUR) Survival ratio IBNR factor = add. reserves/case reserves 2007 26,532 119,192 145,724 5,555 26.2 4.5 2008 22,988 127,164 150,152 6,008 25.0 5.5 2009 26,216 171,363 197,579 8,130 24.3 6.5 2010 29,099 182,489 211,588 9,270 22.8 6.3 2011 28,422 193,957 222,379 8,574 25.9 6.8 14 Further insights into our reserving policy

Internal reserve studies 2009-2011 reviewed by Towers Watson show increasing redundancies* For the HR Group, over the last 3 years, on average 3.2% of the net earned loss ratio for non-life business is due to reserve redundancy increases in m. EUR Year Redundancy Increase buffer Non-life premium (net earned) 2009 867 276 5,230 2010 956 89 5,394 2011 1,117 162 5,961 2009-2011 total 2009-2011 average 527 176 5,528 The estimated reserve redundancy increased in 2011 despite a high large loss burden in FY 2011 * Redundancy of loss and loss adjustment expense reserve for its non-life insurance business against held IFRS reserves, before tax and minority participations. Towers Watson reviewed these estimates - more details shown in slide 25 (appendix) 15 Further insights into our reserving policy

"We manage risks actively" as a strategic principle......is the basis for our Risk Management Corporate strategy Performance Excellence Risk strategy Increasing degree of detail of the rules Risk Management Framework Guideline Process Management System of limits and thresholds for the material risks of the HR Group Central guidelines: investment, exposure mgmt., central underwriting guidelines (life/non-life),... Internal Control System Local guidelines: e.g. local underwriting guidelines, signature rules, local contingency plans, deputising arrangements,... 16 Further insights into our reserving policy

Group-wide Risk Management roll-out Visit of all subsidiaries and branches Europe Spain Madrid Ireland Dublin Great Britain London France Paris Germany Hannover Italy Milan Sweden Stockholm Asia South Korea Seoul America Canada Toronto Japan Tokyo USA Charlotte Chicago Denver Orlando Bermuda Hamilton Mexico Mexico City Colombia Bogotá Brazil Rio de Janeiro Africa South Africa Johannesburg Australia Australia Sydney Bahrain Manama Taiwan Taipei China Hong Kong Shanghai India Mumbai Malaysia Kuala Lumpur Home Office Subsidiaries Branches (+ 1 rep. office) 17 Further insights into our reserving policy

Group-wide Risk Management Roll-Out Triggered activities Roll out has led to a robust structure and a trustful network Implementation of organisational features at subsidiary level: Position of a Chief Risk Officer or of a risk monitoring responsible Reporting dotted line to Group CRO Implementation of risk committees Group CRO or head of Group Risk Management involved in activities of local risk committees Implementation of risk working groups Group-wide risk documentation cascaded down at subsidiary level also taking into account the local business and the local requirements: Local risk strategy Risk management policy System of limits & thresholds 18 Further insights into our reserving policy

Enterprise Risk Management @ Hannover Re S&P's ERM Level III assessment with positive results Based on a long-standing culture of risk management Overall S&P ERM rating: Strong (Excellent/Strong/Adequate/Weak) In the context of ERM Level III, S&P assessed Hannover Re's economic capital model in 2011 for the first time Overall result of S&P's model review: Good (Superior/Good/Basic) This model review has led to a benefit in S&P's assessment of Hannover Re's capital adequacy Sources: A New Level Of Enterprise Risk Management Analysis: Methodology For Assessing Insurers' Economic Capital Models, S&P, 24/01/2011, republished 26/10/2011 Hannover Re Group Rating Report, S&P, 19/06/2012 19 Further insights into our reserving policy

Solvency II to come into force in 2014? Further delays are likely given the tough time schedule 2008 2009 2010 2011 2012 2013 2014 L1 Directive adaption Omnibus II development and discussions L2 Development and finalisation of delegated acts by European Commission Transitional measures L3 Development of further technical standards by EIOPA? 11 Jun 2009 European Parliament approval of directive 18 Sep 2012 Plenary vote on Omnibus II (No agreement achieved) 1 Jul 2013 Phasing-in of Solvency II ( soft launch ) 1 Jan 2014/15/16 Solvency II is effective 20 Further insights into our reserving policy

Hannover Re will apply for full internal model application Reinsurer's risk profile not adequately captured by the standard formula The capital models under Solvency II Standard model with simplifications Standard Standard model Standard model and undertaking specific parameters Standard model and partial internal model (Full) Internal model Individual We have invested significantly to make our internal model Solvency II compliant 21 Further insights into our reserving policy

Hannover Re is prepared for Solvency II We expect a strengthening of the role of reinsurance Solvency II Pillar I Quantitative requirements Solvency/minimum capital requirement (SCR/MCR) Available fin. resources Standard & internal model Pillar II Qualitative requirements Internal controls and risk mgmt. Internal risk assessment Supervisory activities Hannover Re Pillar III Reporting requirements Supervisory reporting Public disclosure Market discipline We applied for internal model approval to align regulatory capital requirements with our business model Internal model framework already in use for several years; Solvency II governance rules impose additional costs Strong internal controls and risk management processes are in place Solvency II is missing an adequate group framework such that focus is placed on legal entities We support our clients in their preparations via flexible product design and by sharing our experience Reporting requirements are overly burdensome and impose additional costs on policy holders 22

More chances than risks from Solvency II We will be able to assist our clients Opportunity... We anticipate positive implications of Solvency II for the risk management systems of insurers and the transparency of the insurance market (even before actual legal effectiveness) As a consequence, we expect an increasing importance of reinsurance solutions...and Challenge The principle of proportionality must be carefully applied by the supervisor to ensure that small and medium-sized insurers can comply It is important to apply Solvency II as a principle based system. The application in a rule based manner would lead to excessive capital, governance and reporting requirements and would thus jeopardize the purpose of Solvency II 23 Further insights into our reserving policy

DETAILS ON RESERVE REVIEW BY TOWERS WATSON The scope of Towers Watson s work was to review certain parts of the held loss and loss adjustment expense reserve, net of outwards reinsurance, from Hannover Rückversicherungs s consolidated financial statements in accordance with IFRS as at 31 December 2009, 2010 and 2011, and the implicit redundancy margin, for the non-life business of Hannover Rückversicherung. Towers Watson concludes that the reviewed loss and loss adjustment expense reserve, net of reinsurance, less the redundancy margin is reasonable in that it falls within Towers Watson s range of reasonable estimates. Life reinsurance and health reinsurance business are excluded from the scope of this review Review of non-life reserves as per 31 December 2011 covered 98.8% of gross held reserves of 18.0 billion and 99.0% of net held reserves of 16.7 billion. Together with life loss reserves of gross 2.7 billion and net 2.5 billion, the total balance sheet reserves amount to 20.8 billion gross and 19.2 billion net. The results shown in this presentation are based on a series of assumptions as to the future. It should be recognised that actual future claim experience is likely to deviate, perhaps materially, from Towers Watson s estimates. This is because the ultimate liability for claims will be affected by future external events; for example, the likelihood of claimants bringing suit, the size of judicial awards, changes in standards of liability, and the attitudes of claimants towards the settlement of their claims. The results shown in Towers Watson s reports are not intended to represent an opinion of market value and should not be interpreted in that manner. The reports do not purport to encompass all of the many factors that may bear upon a market value. Towers Watson s analysis was carried out based on data as per the valuation dates of 31 December 2009, 2010 and 2011, respectively. Towers Watson s analysis may not reflect development or information that became available after the valuation dates and Towers Watson s results, opinions and conclusions presented herein may be rendered inaccurate by developments after the valuation dates. As is typical for reinsurance companies, the claims reporting can be delayed due to late notifications by some cedants. This increases the uncertainty in the estimates. Hannover Rückversicherung has asbestos, environmental and other health hazard (APH) exposures which are subject to greater uncertainty than other general liability exposures. Towers Watson s analysis of the APH exposures assumes that the reporting and handling of APH claims is consistent with industry benchmarks, however, there is wide variation in estimates based on these benchmarks. Thus, although Hannover Rückversicherung s held reserves show some redundancy compared to the indications, the actual losses could prove to be significantly different than both the held and indicated amounts. Towers Watson has not anticipated any extraordinary changes to the legal, social, inflationary or economic environment, or to the interpretation of policy language, that might affect the cost, frequency, or future reporting of claims. In addition, Towers Watson s estimates make no provision for potential future claims arising from causes not substantially recognised in the historical data (such as new types of mass torts or latent injuries, terrorist acts), except in so far as claims of these types are included incidentally in the reported claims and are implicitly developed. In accordance with the scope Towers Watson s estimates are on the basis that all of Hannover Rückversicherung s reinsurance protection will be valid and collectable. Further liability may exist for any reinsurance that proves to be irrecoverable. Towers Watson s analysis was carried out based on data as per the valuation dates of 31 December 2009, 2010 and 2011, respectively. Towers Watson s analysis may not reflect development or information that became available after the valuation dates and Towers Watson s results, opinions and conclusions presented herein may be rendered inaccurate by developments after the valuation dates. The estimates are in Euros based on the exchange rates as per 31 December 2009, 2010 and 2011, respectively, and as provided by Hannover Rückversicherung, but a substantial proportion of the liabilities is denominated in foreign currencies. To the extent that the assets backing the reserves are not held in matching currencies, future changes in exchange rates may lead to significant exchange gains or losses. Towers Watson has not attempted to determine the quality of the current asset portfolio of Hannover Rückversicherung, nor has Towers Watson reviewed the adequacy of the balance sheet provisions except as otherwise disclosed herein. In Towers Watson s work, Towers Watson have relied on audited and unaudited financial information and data supplied to us by Hannover Rückversicherung and its subsidiaries, including information given orally and on information from a range of other sources. Towers Watson relied on the accuracy and completeness of this information without independent verification. Except for any responsibilities Towers Watson may have to Hannover Rückversicherung arising under German law, Towers Watson do not assume any responsibility and will not accept any liability to any person for any damages suffered by such person arising out of this letter or Towers Watson s statement. I

Disclaimer This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities. While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information. Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re. Hannover Rückversicherung AG. All rights reserved. Hannover Re is the registered service mark of Hannover Rückversicherung AG.